May 2017: The Antibody Update

In the May Antibody Update, you can expect to find news of an enzyme inhibitor that increases the efficacy of anti-PD-1 Immunotherapy, the generation of induced pluripotent blood stem cells, and the rapid employment of the latest Ebola vaccine in the Democratic Republic of the Congo. Learn more at ProSci.

April 2017: The Antibody Update

In the April 2017 Antibody Update, ProSci presents to you a virucidal peptide found in the skin of frogs, evidence of new and hopeful RNA-drugs, and the innate immune systems role in congenital autoimmunity. 

January 2017: The Antibody Update

The start of the new year has brought some interesting new stories in science and science policy. This Antibody Update looks at The Reproducibility Project's efforts in cancer drug research, changes to encourage vaccine development against less known, but still threatening viruses, and a new study on the mechanism of how macrophages cross the vascular endothelium.

December 2016: The Antibody Update

ProSci's last Antibody Update of 2016 includes the super effective Ebola vaccine developed by Merck, using the common diabetes drug metformin and the antihypertensive syrosingopine to combat cancer, and a link to a highlight review of the immune checkpoint TIGIT. Check it out!

November 2016: The Antibody Update

This months Antibody Update features the first use of CRISPR-Cas9 modified cells being used as therapeutics, the launch of the first vaccine against malaria, and the 21st Century Cures act, which may vastly increase funding of public health agencies for the next decade. Learn more here.

ProSci's HIV Research

ProSci has devoted the last several years to the development of a vaccine for HIV. This blog is a summary of where our research started, what we have accomplished, and where our future research is heading.

July 2016: The Antibdy Update

This Antibody Update's news includes the discovery of a new MRSA antibiotic found in the nose, the newest map of the human brain, and the discovery of a neutralizing antibody against the highly conserved HA stalk of inluenza. Check it out on ProSci's blog.

ProSci's Antibody Expert's Published in Vaccine!

Last month, the latest ProSci research on the HIV vaccine development was published in the scientific journal Vaccine. Here is a background on the work ProSci has done developing a vaccine against the HIV glycoproteins.